Reata Pharmaceuticals, Inc.
Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof

Abstract:

The present invention provides methods of treating or preventing Alport syndrome in a patients in need thereof using bardoxolone methyl or analogs thereof, and/or improving the kidney function of patients who have been diagnosed with Alport syndrome.